University of Cincinnati Researchers Discover Biomarker, Potential Targeted Therapy for Pancreatic Cancer

Published: Oct 07, 2013

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

University of Cincinnati (UC) researchers have discovered a biomarker, known as phosphatidylserine (PS), for pancreatic cancer that could be effectively targeted, creating a potential therapy for a condition that has a small survival rate. These findings, being published in the Oct. 4, 2013, online edition of PLOS ONE, also show that the use of a biotherapy consisting of a lysosomal protein, known as saposin C (SapC), and a phospholipid, known as dioleoylphosphatidylserine (DOPS), can be combined into tiny cavities, or nanovesicles, to target and kill pancreatic cancer cells.

Hey, check out all the research scientist jobs. Post your resume today!

Back to news